Precigen
PGEN
$1.42
Share price
1.06%
Change (1 day)
17.77%
Change (1 year)
Categories
Earnings for Precigen (PGEN)
Earnings in 2023 (TTM): -$96.37 M
According to Precigen's latest financial reports the company's current earnings (TTM) are -$96.37 M. In 2022 the company made an earning of -$79.97 M an increase over its 2021 earnings that were of -$0.11 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Precigen from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$96.37 M | 20.5% |
| 2022 | -$79.97 M | -23.33% |
| 2021 | -$0.11 B | 60.11% |
| 2020 | -$65.15 M | -65.1% |
| 2019 | -$0.19 B | -65.19% |
| 2018 | -$0.54 B | 313.44% |
| 2017 | -$0.13 B | -33.2% |
| 2016 | -$0.2 B | 123.22% |
| 2015 | -$86.98 M | 1.47% |
| 2014 | -$85.72 M | 109.54% |
| 2013 | -$40.91 M | -50.04% |
| 2012 | -$81.88 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$19.09 M | -80.20% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$73.07 M | -24.18% | 🇬🇧 UK |
 Novavax NVAX | -$0.53 B | 448.57% | 🇺🇸 USA |
 Novocure
NVCR | -$0.19 B | 95.53% | Jersey |